Treatment Case of Asymptomatic Prostate Tuberculosis That Developed After Bacillus Calmette-Guerin Intravesical Therapy in a Patient With Nonmuscle Invasive Bladder Cancer.
10.22465/kjuo.2017.15.2.85
- Author:
Jong Won KIM
1
;
Suk Young LEE
;
Yee Jeong KIM
;
Sang Hee CHOI
Author Information
1. Department of Urology, National Health Insurance Service Ilsan Hospital, Goyang, Korea. uroyoung@nhimc.or.kr
- Publication Type:Case Report
- Keywords:
Prostate tuberculosis;
Bacillus Calmette-Guerin;
Bladder cancer
- MeSH:
Abscess;
Bacillus*;
Biopsy;
Humans;
Mycobacterium bovis;
Prostate*;
Prostate-Specific Antigen;
Prostatitis;
Recurrence;
Tuberculosis*;
Ultrasonography;
Urinary Bladder Neoplasms*;
Urinary Bladder*
- From:Korean Journal of Urological Oncology
2017;15(2):85-87
- CountryRepublic of Korea
- Language:English
-
Abstract:
Intravesical Bacillus Calmette-Guerin (BCG) therapy after transurethral resection of bladder tumor is considered the most effective treatment for prophylaxis against the recurrence of high risk nonmuscle invasive bladder cancer, and generally well tolerated and infectious complication are rare. We reported a case of granulomatous prostatitis is a patient who had undergone intravesical BCG therapy due to nonmuscle invasive bladder cancer. This patient was diagnosed by prostate biopsy because of prostate-specific antigen elevation without any other voiding symptoms and abnormal abscess pocket in transrectal ultrasonography.
